Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Oct 19;4(5937):121–122.

Editorial: Rauwolfia and breast cancer.

PMCID: PMC1612295  PMID: 4423116

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B., Stevens N., Doll R. Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women. Lancet. 1974 Sep 21;2(7882):672–675. doi: 10.1016/s0140-6736(74)93258-9. [DOI] [PubMed] [Google Scholar]
  2. Carstairs K. C., Breckenridge A., Dollery C. T., Worlledge S. M. Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet. 1966 Jul 16;2(7455):133–135. doi: 10.1016/s0140-6736(66)92422-6. [DOI] [PubMed] [Google Scholar]
  3. Heinonen O. P., Shapiro S., Tuominen L., Turunen M. I. Reserpine use in relation to breast cancer. Lancet. 1974 Sep 21;2(7882):675–677. doi: 10.1016/s0140-6736(74)93259-0. [DOI] [PubMed] [Google Scholar]
  4. Pearson O. H., Llerena O., Llerena L., Molina A., Butler T. Prolactin-dependent rat mammary cancer: a model for man? Trans Assoc Am Physicians. 1969;82:225–238. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES